USA flag logo/image

An Official Website of the United States Government

RESETTABLE-PRESSURE HYDROCEPHALIC SHUNT W/REMOTE READOUT

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
16775
Program Year/Program:
1991 / SBIR
Agency Tracking Number:
16775
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Frontier Technology, Inc.
75 Aero Camino, Suite A Goleta, CA 93117-3134
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1991
Title: RESETTABLE-PRESSURE HYDROCEPHALIC SHUNT W/REMOTE READOUT
Agency: HHS
Contract: N/A
Award Amount: $49,717.00
 

Abstract:

THE ULTIMATE OBJECTIVE OF THIS EFFORT IS TO DEVELOP A HYDROCEPHALIC SHUNT THAT INCORPORATES A RESETTABLE-PRESSURE VALVE MECHANISM AND AN INTRACRANIAL PRESSURE (ICP) SENSOR WITH REMOTE READ-OUT DISPLAY. THE PURPOSE FOR THIS DEVICE IS TO PROVIDE NEUROSURGEONS WITH A SHUNT THAT CAN BE ADJUSTED AT ANY TIME SO AS TO IMPROVE DEGREE OF CONTROL OVERTHE ICP, AND THEREBY IMPROVE THE QUALITY OF HEALTH CARE. IN ADDITION, THE REMOTE READ-OUT FEATURE ENABLES THE NEUROSURGEON (OR HEALTH CARE WORKER) TO MONITOR THE PATIENT'S ICP ON A REGULAR AND/OR LONG-TERM BASIS. THIS FEATURE MAY BE DEVELOPED INDEPENDENTLY FOR APPLICATIONS NOT REQUIRING SHUNTING OF THE CEREBROSPINAL FLUID, SUCH AS MONITORING THE ICP IN A PATIENT WITH A BRAIN TUMOR. THE DESIGN CONCEPT WILL BE REFINED BY THE PRINCIPAL INVESTIGATOR IN CONJUNCTION WITH THE DIRECTOR OF R&D FOR HELIX MEDICAL UNDER THE PHASE I EFFORT. HELIX WILL DEVELOP A BENCH-TEST AND EVALUATION. A "FORM-FIT" VERSION IS PLANNED FOR PHASE II, WHICH WILL UNDERGO ANIMAL TESTS. IT IS ESTIMATED THAT THERE WOULD BE A MARKET FOR OVER 100,000 OF THESE DEVICES PER YEAR. THE ULTIMATE OBJECTIVE OF THIS EFFORT IS TO DEVELOP A HYDROCEPHALIC SHUNT THAT INCORPORATES A RESETTABLE-PRESSURE VALVE MECHANISM AND AN INTRACRANIAL PRESSURE (ICP) SENSOR WITH REMOTE READ-OUT DISPLAY. THE PURPOSE FOR THIS DEVICE IS TO PROVIDE NEUROSURGEONS WITH A SHUNT THAT CAN BE ADJUSTED AT ANY TIME SO AS TO IMPROVE DEGREE OF CONTROL OVERTHE ICP, AND THEREBY IMPROVE THE QUALITY OF HEALTH CARE. IN ADDITION, THE REMOTE READ-OUT FEATURE ENABLES THE NEUROSURGEON (OR HEALTH CARE WORKER) TO MONITOR THE PATIENT'S ICP ON A REGULAR AND/OR LONG-TERM BASIS. THIS FEATURE MAY BE DEVELOPED INDEPENDENTLY FOR APPLICATIONS NOT REQUIRING SHUNTING OF THE CEREBROSPINAL FLUID, SUCH AS MONITORING THE ICP IN A PATIENT WITH A BRAIN TUMOR. THE DESIGN CONCEPT WILL BE REFINED BY THE PRINCIPAL INVESTIGATOR IN CONJUNCTION WITH THE DIRECTOR OF R&D FOR HELIX MEDICAL UNDER THE PHASE I EFFORT. HELIX WILL DEVELOP A BENCH-TEST AND EVALUATION. A "FORM-FIT" VERSION IS PLANNED FOR PHASE II, WHICH WILL UNDERGO ANIMAL TESTS. IT IS ESTIMATED THAT THERE WOULD BE A MARKET FOR OVER 100,000 OF THESE DEVICES PER YEAR.

Principal Investigator:

William Elliot
8059652477

Business Contact:

Small Business Information at Submission:

Frontier Technology Inc
530 E Montecito St #105 Santa Barbara, CA 93103

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No